COMMUNIQUÉS West-GlobeNewswire

Retrophin Announces Appointment of Casey Logan as Vice President of Corporate Development

05/03/2018 - 22:30

SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that Casey Logan has joined the Company as vice president, corporate development. Mr. Logan will report to chief operating [...]

Dynavax to Present at the Cowen & Co. Annual Health Care Conference

05/03/2018 - 22:30

BERKELEY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) announced today that Eddie Gray, Dynavax’s Chief Executive Officer, will present at the Cowen & Co. 38 th Annual [...]

G1 Therapeutics Announces Proposed Offering of Common Stock

05/03/2018 - 22:18

RESEARCH TRIANGLE PARK, N.C., March 05, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced that it has commenced an underwritten public offering of 3,000, [...]

AnaptysBio Announces Fourth Quarter and Full Year 2017 Financial Results and 2018 Pipeline Milestones

05/03/2018 - 22:15

ANB020 Top-Line Phase 2a Readouts Anticipated For Peanut Allergy in March 2018 and Eosinophilic Asthma in Second Quarter 2018 ANB019 GPP and PPP Phase 2 Studies to be Initiated During 2018 SAN DIEGO, March 05, 2018 ( [...]

SELLAS Life Sciences to Present at the 30th Annual ROTH Conference

05/03/2018 - 22:15

NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]

Analogic Announces Results for the Second Quarter ended January 31, 2018 and Declares Quarterly Cash Dividend

05/03/2018 - 22:15

PEABODY, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (Nasdaq: ALOG ), enabling the world's medical imaging and aviation security technology, today announced results for its second quarter ended [...]

Portola Pharmaceuticals to Host Webcast Event and Conference Call at ACC.18 to Discuss Late-Breaking Oral Presentation Highlighting New Interim Data for Andexanet Alfa

05/03/2018 - 22:10

SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA ) today announced that it will host a live audio webcast and conference call on Monday, March 12, 2018 at the [...]

GBT Announces Participation at Upcoming Investor Conferences in March

05/03/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that it will present at the following investor conferences in March 2018: Cowen and [...]

Kura Oncology to Report Fourth Quarter and Full Year 2017 Financial Results

05/03/2018 - 22:05

SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA ), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that it will [...]

Anthera Pharmaceuticals Provides Business Update and Reports 2017 Fourth Quarter and Fiscal Year Financial Results

05/03/2018 - 22:05

RESULT study reported positive interim futility analyses and completion of dosing, with top line data expected in March 2018 Completed private placement for net proceeds of $13.3 million Received net proceeds of $3.1 [...]

Aeterna Zentaris Appoints James Clavijo as Chief Financial Officer

05/03/2018 - 22:05

CHARLESTON, S.C., March 05, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) today announced the appointment of James Clavijo as Chief Financial Officer effective March 5, 2018. Mr. Clavijo [...]

Aduro Announces Milestone Achieved under Merck Collaboration for Initiation of Anti-CD27 Phase I Trial in Advanced Solid Tumors

05/03/2018 - 22:05

BERKELEY, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today announced that the company earned a $3.0 million development milestone payment under its worldwide licensing agreement with [...]

Ovid Therapeutics to Present at Two Upcoming Investor Conferences

05/03/2018 - 22:05

NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines for patients with rare neurological disorders, today announced that [...]

GBT Announces New Employment Inducement Grants

05/03/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT or the Company) (NASDAQ: GBT ) today announced that on March 1, 2018, the compensation committee of the Company’s [...]

Alder BioPharmaceuticals® to Present at 38th Annual Cowen & Co. Health Care Conference

05/03/2018 - 22:05

BOTHELL, Wash., March 05, 2018 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR ), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

Joseph Darling Named CEO and Director of Anika Therapeutics

05/03/2018 - 22:02

BEDFORD, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK ) today announced the appointment of Joseph Darling as Chief Executive Officer, succeeding Dr. Charles Sherwood, who will retire [...]

Catalyst Biosciences Announces the Calling of Remaining Warrants and Conversion of Remaining Series A Preferred Shares Issued April 12, 2017

05/03/2018 - 22:01

Total of 11.9 million common shares outstanding post-conversion and warrant exercise SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (Nasdaq: CBIO ), a clinical-stage [...]

Endocyte to Present at the Cowen and Company 38th Annual Health Care Conference

05/03/2018 - 22:01

WEST LAFAYETTE, March 05, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment , today announced that the company’s [...]

Spring Bank Pharmaceuticals Appoints Timothy Clackson, Ph.D., to its Board of Directors

05/03/2018 - 22:01

Spring Bank strengthens Board of Directors with the addition of a prominent biopharma R&D veteran HOPKINTON, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH ), a clinical- [...]